Fight tumors and infections with targeted drugs
By Cynthia Lee
Some drug regimens, such as those designed to eliminate tumors, are notorious for nasty side effects. Unwanted symptoms are often the result of medicine going where it鈥檚 not needed and harming healthy cells. To minimize this risk, researchers in Quebec have developed nanoparticles that only release a drug when exposed to near-infrared light, which doctors could beam onto a specific site. Their report appears in the Journal of the American Chemical Society.
For years, scientists have been striving to develop localized treatments to reduce side effects of therapeutic drugs. They have designed drug-delivery systems that respond to light, temperature, ultrasound and pH changes. One promising approach involved drug-carrying materials that are sensitive to ultraviolet (UV) light. Shining a beam in this part of the light spectrum causes the materials to release their therapeutic cargo at a designated location. But UV light has major limitations. It can鈥檛 penetrate body tissues, and it is carcinogenic. Near-infrared (NIR) light can go through 1 to 2 centimeters of tissue and would be a safer alternative, but photosensitive drug-carriers don鈥檛 react to it. 91社区 engineering professor Marta Cerruti and colleagues sought a way to bring the two kinds of light together in one possible solution.
You may also like
The researchers started with nanoparticles that convert NIR light into UV light and coated them in a UV-sensitive hydrogel shell infused with a fluorescent protein, a stand-in for drug molecules. When exposed to NIR light, the nanoparticles instantaneously converted it to UV, which induced the shell to release the protein payload. The researchers note that their on-demand delivery system could not only supply drug molecules but also agents for imaging and diagnostics.
The authors acknowledge funding from the , , , and 91社区.
鈥淧hotocleavable Hydrogel Coated Upconverting Nanoparticles: a Multifunctional Theranostic Platform for NIR Imaging and On-Demand Macromolecular Delivery鈥�, Ghulam Jalani, Rafik Naccache, Derek H. Rosenzweig, Lisbet Haglund, Fiorenzo Vetrone, and Marta Cerruti are published in the Journal of the American Chemical Society
To contact the researcher directly: marta.cerruti [at] mcgill.ca
